Related Experiment Video
Updated: Mar 26, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Gain-of-function miRNA signature by mutant p53 associates with poor cancer outcome
Yao Zhang1, Ye Hu1,2, Jing-Yuan Fang1
1State Key Laboratory for Oncogenes and Related Genes, Key Laboratory of Gastroenterology and Hepatology, Ministry of Health, Division of Gastroenterology and Hepatology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai Institute of Digestive Disease, Shanghai Cancer Institute, Shanghai, China.
Abstract:
Missense mutation of p53 not only impairs its tumor suppression function, but also causes oncogenic gain of function (GOF). The molecular underpinning of mutant p53 (mutp53) GOF is not fully understood, especially for the potential roles of non-coding genes. Here we identify the microRNA expression profile (microRNAome) of mutp53 on Arg282 by controlled microarray experiments, and clarify the prognostic significance of mutp53-regulated miRNAs in cancers. A predominant repression effect on miRNA expression was found for mutant p53, with 183 significantly downregulated and only 12 upregulated miRNAs. Mutp53 and wild-type (wtp53) commonly upregulate let-7i, and other two miRNAs were upregulated by wtp53 but repressed by mutp53 (miR-610 and miR-3065-3p). Based the mutp53-regulated miRNA signature, a non-negative matrix factorization (NMF) model classified gastric cancer (GC) cases into subgroups with significantly different Disease-free survival (Kaplan-Meier test, P = 0.013). In contrast, the NMF model based on all miRNAs did not associate with cancer outcome. The mutp53 miRNA signature associated with the outcomes of breast cancer (P = 0.024) and hepatocellular cancer (P = 0.012). The miRPath analysis revealed that mutp53-suppressed miRNAs associate with Hippo, TGF-β and stem cell signaling pathways. Taken together, our results highlight a miRNA-mediated GOF mechanism of mutant p53 on Arg282, and suggest the prognostic potential of mutp53-associated miRNA signature.
Insights
Mutant p53 (mutp53) gain-of-function involves microRNAs (miRNAs). A mutp53-regulated miRNA signature predicts outcomes in gastric, breast, and liver cancers, revealing a novel oncogenic mechanism.
Area of Science:
- Molecular oncology
- Cancer genomics
- Non-coding RNA research
Background:
- Missense mutations in p53 impair tumor suppression and confer oncogenic gain-of-function (GOF).
- The molecular mechanisms underlying mutp53 GOF, particularly the role of non-coding genes like microRNAs, remain incompletely understood.
Purpose of the Study:
- To identify the microRNA expression profile regulated by mutant p53 (mutp53) at Arg282.
- To investigate the prognostic significance of mutp53-regulated microRNAs in various human cancers.
Main Methods:
- Controlled microarray experiments to profile microRNAome associated with mutp53 Arg282.
- Non-negative matrix factorization (NMF) model to analyze microRNA signatures and patient outcomes.
- Kaplan-Meier survival analysis and miRPath pathway analysis.
Main Results:
- Mutant p53 predominantly represses microRNA expression, with 183 downregulated and 12 upregulated miRNAs identified.
- A mutp53-regulated miRNA signature significantly predicted disease-free survival in gastric cancer (P = 0.013).
- This signature also showed prognostic value in breast (P = 0.024) and hepatocellular cancers (P = 0.012), unlike models based on all miRNAs.
Conclusions:
- Mutant p53 Arg282 exerts a predominant repressive effect on microRNA expression.
- A specific mutp53-associated miRNA signature holds significant prognostic potential across multiple cancer types.
- These findings suggest a microRNA-mediated mechanism contributing to mutp53 GOF and cancer progression.
More Related Videos
04:56Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
Published on: December 30, 2025
09:40Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
Published on: October 4, 2019
Related Concept Videos
Abnormal Proliferation
MicroRNAs
MicroRNAs
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...